CrownBio exclusively provides preclinical oncology drug development and validation services using unique 3D organoid models developed using IP-protected Hubrecht Organoid Technology (HUB) protocols, as well as HUB’s biobank of already established patient-derived organoids (PDO).

Continue Reading